Connect with us

Health

Eleanor Maguire, Memory Expert Who Studied London Cabbies, Dies at 54

Published

on

Eleanor Maguire, Memory Expert Who Studied London Cabbies, Dies at 54

Eleanor Maguire, a cognitive neuroscientist whose research on the human hippocampus — especially those belonging to London taxi drivers — transformed the understanding of memory, revealing that a key structure in the brain can be strengthened like a muscle, died on Jan. 4 in London. She was 54.

Her death, at a hospice facility, was confirmed by Cathy Price, her colleague at the U.C.L. Queen Square Institute of Neurology. Dr. Maguire was diagnosed with spinal cancer in 2022 and had recently developed pneumonia.

Working for 30 years in a small, tight-knit lab, Dr. Maguire obsessed over the hippocampus — a seahorse-shaped engine of memory deep in the brain — like a meticulous, relentless detective trying to solve a cold case.

An early pioneer of using functional magnetic resonance imaging (f.M.R.I.) on living subjects, Dr. Maguire was able to look inside human brains as they processed information. Her studies revealed that the hippocampus can grow, and that memory is not a replay of the past but rather an active reconstructive process that shapes how people imagine the future.

“She was absolutely one of the leading researchers of her generation in the world on memory,” Chris Frith, an emeritus professor of neuropsychology at University College London, said in an interview. “She changed our understanding of memory, and I think she also gave us important new ways of studying it.”

Advertisement

In 1995, while she was a postdoctoral fellow in Dr. Frith’s lab, she was watching television one evening when she stumbled on “The Knowledge,” a quirky film about prospective London taxi drivers memorizing the city’s 25,000 streets to prepare for a three-year-long series of licensing tests.

Dr. Maguire, who said she rarely drove because she feared never arriving at her destination, was mesmerized. “I am absolutely appalling at finding my way around,” she once told The Daily Telegraph. “I wondered, ‘How are some people so bloody good and I am so terrible?’”

In the first of a series of studies, Dr. Maguire and her colleagues scanned the brains of taxi drivers while quizzing them about the shortest routes between various destinations in London.

The results, published in 1997, showed that blood flow in the right hippocampus increased sharply as the drivers described their routes — meaning that specific area of the brain played a key role in spatial navigation.

But that didn’t solve the mystery of why the taxi drivers were so good at their jobs.

Advertisement

Dr. Maguire kept digging. Using M.R.I. machines, she measured different regions in the brains of 16 drivers, comparing their dimensions with those in the brains of people who weren’t taxi drivers.

“The posterior hippocampi of taxi drivers were significantly larger relative to those of control subjects,” she wrote in Proceedings of the National Academy of Sciences. And the size, she found, correlated with the length of a cabby’s career: The longer the cabby had driven, the bigger the hippocampus.

Dr. Maguire’s study, published in March 2000, generated headlines around the world and turned London taxi drivers into unlikely scientific stars.

“I never noticed part of my brain growing,” David Cohen, a member of the London Cab Drivers Club, told the BBC. “It makes you wonder what happened to the rest of it.”

Dr. Maguire wondered, too: Why (and how) did their hippocampi grow?

Advertisement

She followed up with other studies. One showed that the hippocampi of bus drivers — whose routes were set rather than navigated from memory — didn’t grow. Another showed that prospective taxi drivers who failed their tests did not gain any hippocampus volume in the process.

The implications were striking: The key structure in the brain governing memory and spatial navigation was malleable.

In a roundabout way, Dr. Maguire’s findings revealed the scientific underpinnings of the ancient Roman “method of loci,” a memorization trick also known as the “memory palace.”

This technique involves visualizing a large house and assigning an individual memory to a particular room. Mentally walking through the house fires up the hippocampus, eliciting the memorized information. Dr. Maguire studied memory athletes — people who train their brains to memorize vast amounts of information quickly — who used this method, and observed that its effectiveness was “reflected in its continued use over two and a half millennia in virtually unchanged form.”

But recalling information was only half the story.

Advertisement

In studying patients with damage to the hippocampus, including those with amnesia, Dr. Maguire found that they couldn’t visualize or navigate future scenarios. One taxi driver, for instance, struggled to make his way through busy London streets in a virtual-reality simulation. Other amnesiacs couldn’t imagine an upcoming Christmas party or a trip to the beach.

“Instead of visualizing a single scene in their mind, such as a crowded beach filled with sunbathers, the patients reported seeing just a collection of disjointed images, such as sand, water, people and beach towels,” the journal Science News reported in 2009.

The hippocampus, it turns out, binds snippets of information to construct scenes from the past — and the future.

“The whole point of the brain is future planning,” Dr. Maguire was quoted as saying in Margaret Heffernan’s book “Uncharted: How to Navigate the Future” (2020). “You need to survive and think about what happened when I was last here, is there a scary monster that will come out and eat me? We create models of the future by recruiting our memories of the past.”

Eleanor Anne Maguire was born on March 27, 1970, in Dublin. Her father, Paddy Maguire, was a factory worker. Her mother, Anne Maguire, was a receptionist.

Advertisement

Growing up, Eleanor was obsessed with “Star Trek.”

“My first scientific hero was fictional — Spock, science officer on the Starship Enterprise,” she told the journal Current Biology in 2012. “He embodied so much of what attracted me to science. He was inquisitive, logical, honest, meticulous, calm, fearless in facing the unknown, innovative and unafraid of taking risks.”

She graduated from University College Dublin in 1990 with a degree in psychology, and returned to earn her doctorate there after receiving a master’s degree from the University College of Swansea (now Swansea University).

Dr. Maguire joined the faculty at University College London in 1995 and never left.

She is survived by her parents. Her brother, Declan, died in 2019, also of cancer.

Advertisement

At Dr. Maguire’s memorial service, Dr. Price spoke about the energy and excitement her friend and longtime colleague generated at the lab, recalling that Dr. Maguire’s mother had called nightly to remind her daughter to go home.

“It wasn’t just a job,” Dr. Price said. “It consumed us, day and night.”

There was a sense that they were onto something big.

“We were among the first to use cutting-edge technology to peer inside the healthy, living human brain and witness its functions in action,” Dr. Price said. “It was an exhilarating and transformative time in neuroscience, and Eleanor’s curiosity and creativity were instrumental to numerous discoveries.”

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Health

Nutrition experts react to new food pyramid, and more of this week’s biggest health stories

Published

on

Nutrition experts react to new food pyramid, and more of this week’s biggest health stories

NEWYou can now listen to Fox News articles!

Top stories

→ Health experts react to the Trump administration’s newly revamped food pyramid

→ Deadly superbug spreads across US as drug resistance grows

→ Common pain relievers may raise heart disease and stroke risk, doctors warn

The Trump administration announced on Wednesday the 2025-2030 Dietary Guidelines for Americans, putting “real food” back at the center of health. (Chance Yeh/Getty Images for HubSpot; iStock)

Advertisement

On the lookout

→ Flu cases spiked in New York State again this week, sparking warnings from health officials

→ Not all cancers should be treated right away, medical experts say

Conversation starters

→ The shape of your butt is an indicator of key health risks — what does yours say about you?

→ Trending “analog bags” are being touted as replacements for smartphones

Healthy living

→ Experimental vaccine could save thousands of lives per year, scientist claims

Advertisement

→ Little-known prescription pill is helping Americans drink less alcohol

Quote of the week

“This is a big deal.” 

Elon Musk announced that Neuralink — the brain implant chip that allows users to communicate using their minds — will start “high-volume” production this year, calling the step a “big deal”

CLICK HERE FOR MORE HEALTH STORIES

Advertisement
Continue Reading

Health

‘Weight Loss Has Never Been About Calories’: How This Low-Insulin Diet Helped Lillie, 58, Drop 70 Lbs!

Published

on

‘Weight Loss Has Never Been About Calories’: How This Low-Insulin Diet Helped Lillie, 58, Drop 70 Lbs!


Advertisement


Low-Insulin Diet Helped Lillie, 58, Drop 70 Lbs, No Calorie Counting! | Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Weight-loss experts predict 5 major treatment changes likely to emerge in 2026

Published

on

Weight-loss experts predict 5 major treatment changes likely to emerge in 2026

NEWYou can now listen to Fox News articles!

Big moves are continuing in the weight loss landscape in the new year following breakthrough research of GLP-1 medications and other methods.

Weight-loss experts spoke with Fox News Digital about their predictions for the most major changes to come in 2026.

No. 1: Shift to whole-body treatment 

Dr. Peter Balazs, a hormone and weight loss specialist in New York and New Jersey, shared that the most important shift is likely to label GLP-1 drugs as “multi-system metabolic modulators” rather than “simple weight loss drugs.”

MORE AMERICANS MAY BE CLASSIFIED AS OBESE UNDER NEW DEFINITION, STUDY SUGGESTS

Advertisement

“The treatment goal is no longer just BMI reduction, but total cardiometabolic risk mitigation, with effects now documented across the liver, heart, kidneys and vasculature,” he said.

“We are seeing a significant reduction in major adverse cardiovascular events … and progression of renal disease,” he went on.

The focus of GLP-1 drugs will widen beyond weight loss and diabetes, according to experts’ predictions. (iStock)

Philip Rabito, M.D., a specialist in endocrinology, weight loss and wellness in New York City, also shared that “exciting” advancements lie ahead for weight-loss drugs, including GLP-1s and GIPs.

OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT-LOSS DRUGS FOR 4 KEY REASONS

Advertisement

“These next‑generation agents, along with novel combinations that include glucagon and amylin agonists, are demonstrating even more impressive weight‑loss outcomes than currently available therapies, with the potential for better tolerability and sustained results,” he told Fox News Digital.

“There is also tremendous optimism around new federal agreements with manufacturers that aim to make these medications more widely accessible and affordable for the broad population of patients who need them most.”

No. 2: More convenient dosing

The typical prescription for a GLP-1 medication is a weekly injection, but delivery and dosing may be changing to more convenient methods in 2026, according to Balazs.

OPRAH JOINS WAVE OF CELEBRITIES WHO REVEALED DRAMATIC WEIGHT LOSS IN 2025

A daily 25 mg pill version of Novo Nordisk’s Wegovy, a semaglutide designed to treat obesity, is now approved and available for chronic weight management, offering a non-injectable option for some patients.

Advertisement

A once-weekly oral GLP-1 is currently in phase 2 trials, as well as an implant that aims for three to six months of drug delivery, Balazs noted.

Incisionless weight-loss procedures will rise as a lower-risk option, according to experts. (iStock)

No. 3: Less invasive surgery

In addition to decreased risk during surgery for GLP-1 users, Balazs also predicted that metabolic surgery without incision will rise as a better option.

“Incisionless endoscopic procedures — like endoscopic sleeve gastroplasty (non-surgical weight-loss procedure that makes the stomach smaller from the inside) and duodenal mucosal resurfacing (non-surgical procedure that resets part of the small intestine to help the body better handle blood sugar) — [may become] more durable and widely available,” he said. 

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

“These offer significant metabolic benefits with shorter recovery and lower risk than traditional surgery.”

Rabito agreed that “rapid progress” in minimally invasive weight‑loss procedures is “opening powerful new options for patients who are hesitant to pursue traditional bariatric surgery.”

Bariatric surgery remains the most effective weight loss method, one specialist says. (iStock)

This avenue offers “meaningful and durable weight reduction with less risk, shorter recovery times and no external incisions,” the expert added.

Dr. Muhammad Ghanem, bariatric surgeon at the Orlando Health Weight Loss & Bariatric Surgery Institute, reiterated that surgery remains “the most successful modality for the treatment of obesity … with the highest weight loss and most durable outcomes as of yet.”

Advertisement

No. 4: Younger GLP-1 users

As Novo Nordisk’s Wegovy has been indicated for adolescents over 12 years old as an obesity treatment, Balazs commented that pediatric use of weight-loss drugs is “now a clinical reality.”

He predicted that other alternatives are likely to be approved in 2026 for younger users.

No. 5: High-tech, personalized access

Amid the growth of artificial intelligence, Balazs predicted an expansion in the clinical implementation of AI-driven weight-loss methods.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

This could include categorizing obesity into sub-types like “hungry brain,” “emotional hunger” and “slow burn” to personalize how therapy is prescribed while moving away from “trial and error,” he said.

Advertisement

Ghanem agreed that there will likely be a “big focus” on individualized testing for causes of obesity in 2026, as it’s a disease that can have “different causes in different people,” thus requiring different treatments.

AI and other digital opportunities will drive more access for weight-loss patients, experts say. (iStock)

The doctor anticipates that more patients will seek combinations of comprehensive treatments and programs.

“Patients are more aware that now we have a few weapons in our arsenal to combat obesity, and [they] are seeking a multidisciplinary and holistic approach,” Ghanem said.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

Treatment options will also turn digital with the rise of prescription digital therapeutics (PDTs) for weight loss, Balazs predicted.

“These are software applications delivering cognitive behavioral therapy, personalized nutrition and metabolic coaching through algorithms, often integrated with continuous glucose monitors, and reimbursed as medical treatments,” he said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Ghanem added that body composition analyzers, like DEXA scans, will likely be more widely used as awareness grows about the limitations of BMI and weight in assessing obesity.

Advertisement
Continue Reading
Advertisement

Trending